Literature DB >> 18421780

Heparin--a unique stimulator of human colon cancer cells' growth.

Georgia Chatzinikolaou1, Dragana Nikitovic, Athanasia Asimakopoulou, Aristidis Tsatsakis, Nikos K Karamanos, George N Tzanakakis.   

Abstract

The cancer microenvironment and the interactions between cancer and surrounding tissue cells are thought to play a pivotal role in tumor development and progression. Glycosaminoglycans (GAGs)/proteoglycans (PGs) are major constituents of the extracellular matrix, the composition of which may affect various cellular functions. In the present study, the effects of GAGs on the proliferation of HT29, SW1116, and HCT116 human colon cancer cell lines were examined using exogenously added GAGs, an inhibitor of endogenous GAG sulfation and specific glycosidase digestions. Our results demonstrate that colon cancer cell growth was exclusively stimulated by exogenously added heparin and insensitive to endogenous GAGs/PGs production, in a sulfation pattern-related manner. Treatment of the tested cell lines with the FGF-2 neutralizing antibody showed that the stimulatory effect of heparin on the cells' growth was not FGF-2-dependent. Responsiveness of colon cancer cell lines to exogenous heparin/heparan sulfate may play a role in their growth and metastasis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18421780     DOI: 10.1002/iub.70

Source DB:  PubMed          Journal:  IUBMB Life        ISSN: 1521-6543            Impact factor:   3.885


  4 in total

1.  Heparin regulates colon cancer cell growth through p38 mitogen-activated protein kinase signalling.

Authors:  G Chatzinikolaou; D Nikitovic; A Berdiaki; A Zafiropoulos; P Katonis; N K Karamanos; G N Tzanakakis
Journal:  Cell Prolif       Date:  2009-10-21       Impact factor: 6.831

2.  Does antithrombotic therapy improve survival with colorectal cancer?

Authors:  Kodai Takahashi; Hideto Ito; Masatoshi Hashimoto; Kazuhito Mita; Hideki Asakawa; Takashi Hayashi; Keiichi Fujino
Journal:  World J Surg Oncol       Date:  2017-08-24       Impact factor: 2.754

3.  Heparin regulates B6FS cell motility through a FAK/actin cytoskeleton axis.

Authors:  Kallirroi Voudouri; Dragana Nikitovic; Aikaterini Berdiaki; Dionysios J Papachristou; John Tsiaoussis; Demetrios A Spandidos; Aristides M Tsatsakis; George N Tzanakakis
Journal:  Oncol Rep       Date:  2016-08-30       Impact factor: 3.906

4.  Antiproliferative Properties of Scandium Exopolysaccharide Complexes on Several Cancer Cell Lines.

Authors:  Javier Muñoz-Garcia; Mattia Mazza; Cyrille Alliot; Corinne Sinquin; Sylvia Colliec-Jouault; Dominique Heymann; Sandrine Huclier-Markai
Journal:  Mar Drugs       Date:  2021-03-23       Impact factor: 5.118

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.